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Abstract
Background: Childhood obesity is one of the most serious, global, public health challenges and has adverse health
consequences in both the short-and long-term. The purpose of this study is to establish the change in body mass
index (BMI) needed to achieve improvements in metabolic health status in obese children and adolescents attending
lifestyle treatment interventions.
Methods: The following electronic databases will be searched from their inception: AMED, Embase, MEDLINE via OVID,
Web of Science and CENTRAL via Cochrane library. Randomised controlled trials (RCTs) or cohort studies of lifestyle
interventions (i.e. dietary, physical activity and/or behavioural therapy) for treating obesity in children and adolescents
(4–18 years) will be included. Interventions that last less than 2 weeks and trials that include overweight participants or
those with a secondary or syndromic cause of obesity will not be included. No language restrictions will be applied.
Titles and abstracts will be assessed for eligibility by two reviewers, and data from full-text articles will be extracted
using a standardised data extraction template. Reference lists of all included articles will be hand-searched for
additional publications. A narrative synthesis of the findings will be presented, and meta-analysis will be
conducted if considered appropriate.
Discussion: This will be the first systematic review of studies to establish the change in BMI required to improve
metabolic health status in obese children and adolescents.
Systematic review registration: PROSPERO CRD42016025317
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Background
Childhood obesity is one of the most serious global pub-
lic health challenges of the twenty-first century [1]. In
England, the latest figures from the National Child
Measurement Programme, which measures the height
and weight of around one million school children every
year, showed that 9.1 % of children aged 4–5 years and
19.1 % of those aged 10–11 years were obese [2].
Childhood obesity has adverse health consequences in
both the short-and long-term. Obese children and
adolescents are at increased risk of developing metabolic
disturbances, including hypertension, dyslipidaemia and
insulin resistance, and they are more likely to become
obese adults [3]. The presence of adverse changes in car-
diac and vascular function and type 2 diabetes, previ-
ously considered adult morbidities, now being identified
in obese children and adolescents [4–10] illustrates the
urgent need for effective weight management treatment
interventions to improve the metabolic health status of
the paediatric population.
Moderate weight loss has been shown to have a posi-
tive impact on a large number of metabolic and cardio-
vascular risk factors [11, 12]. Evidence suggests that
weight loss of 10 % in adults is often associated with
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marked clinical improvement in co-morbidities
and therefore minimum weight management targets can
be set to improve metabolic health in the adult popula-
tion [13].
However, there is very limited evidence in relation to
the amount of weight loss needed to effect beneficial
change in metabolic health in the paediatric population.
Paediatric weight management guidelines exist in many
countries to promote best practice, but at present, many
of these recommendations are based on low-grade scien-
tific evidence [14]. Some studies have reported improve-
ments in parameters of metabolic health as a function of
improvements in measures of adiposity in children and
young people [15–17], but there is yet to be a systematic
quantification of the reduction in body mass or adiposity
needed to achieve these improvements.
Given the scale of the obesity problem and the signifi-
cant and sustained adverse effects on health, clinically
effective treatment options are urgently needed. A
Cochrane review of interventions available for treating
obesity children concluded that combined dietary, phys-
ical activity and behavioural interventions can produce a
significant and clinically relevant reduction in over-
weight in children and adolescents compared to stand-
ard care [14], but whilst most interventions describe
statistically significant reductions in adiposity, few report
on clinical change in metabolic health. This systematic
review aims to establish the minimum change in body
mass index (BMI) needed to improve metabolic health
status in obese children and adolescents to inform clin-
ical guidelines for paediatric weight management inter-
ventions and to guide outcome measures in future
clinical trials.
Objective
The objective of this study is to establish the minimum
change in BMI needed to achieve improvements in
markers of metabolic health in obese children and ado-
lescents attending lifestyle treatment interventions.
Methods
This protocol follows the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses for Protocols
(PRISMA-P) 2015 reporting guideline (see Additional
file 1).
Eligibility criteria
Studies will be selected for inclusion in this review
according to the following criteria:
Study design
Completed, published, randomised controlled trials
(RCTs) and cohort studies, with or without follow-up
periods.
Participants
Studies involving participants aged 4–18 years with a
diagnosis of obesity using defined BMI thresholds. These
thresholds include, but are not limited to, the 98th cen-
tile on the UK 1990 growth reference chart [18], 95th
percentile on the US Centre for Disease Control and
Prevention growth chart [19], the International Obesity
Taskforce BMI for age cut-points [20] and the World
Health Organisation growth references [21, 22], in
addition to country-specific obesity thresholds using
BMI reference data from their paediatric populations.
Studies involving overweight individuals, pregnant fe-
males, the critically ill or those with endocrine disorders
or syndromic obesity will not be included.
Interventions
Lifestyle treatment interventions that include dietary,
physical activity and/or behavioural components with
the objective of reducing obesity. No restrictions will
be applied regarding the setting of the intervention. In-
terventions that last less than 2 weeks and those that
involve surgical and/or pharmacological components
(e.g. bariatric surgery, drug therapy) will not be
included.
Outcomes
To be included, studies must report baseline and post
intervention/change measurements of BMI/BMI stand-
ard deviation score (BMI-SDS or BMI-Z-score) and one
or more of the following markers of metabolic health:
 Glucose
 Insulin sensitivity/resistance (homeostatic model
assessment (HOMA))
 Lipid profile (triglycerides, total cholesterol, low-
density lipoprotein (LDL)/high-density lipoprotein
(HDL) cholesterol)
 Inflammation (C-reactive protein)
 Blood pressure (systolic, diastolic)
 Liver function
 Adiposity measures other than BMI including waist
circumference and percentage body fat. Studies which
report compatible alternative outcome measures (e.g.
linear regression coefficients) will be considered.
Language
No restrictions will be applied regarding language. Non-
English papers will be translated where possible.
Information sources and search methods
Literature search strategies will be developed by an ex-
perienced systematic reviewer (RP) using a combination
of Medical Subject Headings (MeSH) and keyword
terms. The following electronic databases will be
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searched from their inception: AMED, Embase, MED-
LINE via OVID, Web of Science and CENTRAL via
Cochrane library. The search strategy for each database
will be similar but revised appropriately for the specific
database to take into account differences in controlled
vocabulary and syntax rules. To ensure literature satur-
ation, reference lists of all full-text articles will be hand-
searched for additional original publications. Update
searches will be conducted every 6 months to identify
any studies published since the initial search. Conference
abstracts will be used to help identify potential studies
and authors will be contacted to establish if full-text arti-
cles are available.
Study records
Data management
EndNote reference management software package will
be used to manage all the search results throughout the
review period. Literature search results will be imported
into an EndNote library and duplicates will be removed.
Selection process
Titles and abstracts will be assessed for eligibility by two
independent reviewers (LB, RP). Articles that appear to
meet the inclusion criteria will be retrieved in full and
independently considered for inclusion by two reviewers
(LB, JHS). The reviewers will resolve disagreements in
opinion of studies for inclusion through discussion, and
the reasons for excluding studies will be recorded. Refer-
ence lists of included studies will be reviewed, and the
full-text articles of any relevant studies identified will be
retrieved and reviewed for inclusion by both reviewers.
Data collection process
Full-text articles for inclusion will be retrieved, and data
will be extracted independently by two reviewers (LB,
RP) using a standardised data extraction template. The
template will be piloted by both reviewers before starting
the review and modified as required to ensure
consistency. Disagreements in opinion of data extracted
will be resolved through discussion.
Data extraction
The following information will be extracted from each
study:
 Study design (RCT/cohort)
 Definition of obesity
 Sample characteristics (size, inclusion/exclusion
criteria, sex, age, pubertal status, ethnicity,
socioeconomic status)
 Intervention (location, content, format, delivery)
 Metabolic health parameters measured (as described
in the “Outcomes” section)
 Results
 Analysis methods
 Study limitations
Quality assessment
Full-text articles of all included research studies will be
assessed for methodological quality by two independent
reviewers (LB, RP) using the Quality Assessment form
used in the 2004 Health Technology Assessment “System-
atic review of the long-term effects and economic conse-
quences of treatments for obesity and implications for
health improvement” [23]. Any discrepancies between
the two reviewers will be resolved through discussion or
third-party adjudication.
As the focus of this review is the relationship between
change in BMI and change in metabolic health parame-
ters, rather than the specific interventions that effect
these changes, more specific risk of bias tools (e.g.
Cochrane Risk of Bias tool) were not considered appro-
priate for use in this review.
Data synthesis
A narrative synthesis of the findings from the included
studies will be presented, structured around the out-
comes reported. Due to the diverse nature of the studies
of interest, heterogeneity between studies is anticipated
and therefore random effects models will be utilised to
quantitatively synthesise all data where possible. Statis-
tical heterogeneity will be assessed by visual inspection
of forest plots and with the chi2 measurement. Since
heterogeneity is difficult to assess when sample sizes are
small, a cut-off of P < 0.10 for the chi2 measurement will
be used to indicate heterogeneity. The I2 statistic will be
used to measure variation in the effect size due to
heterogeneity, and values greater than 50 % will be indi-
cative of significant heterogeneity [24]. If studies have
non-comparable intervention designs or outcome mea-
sures, we will pool effect sizes for comparable sub-sets
of studies. Original authors will be contacted as required
for any missing data. Where missing data remains, at-
tempts will be made to estimate these missing values
from other results reported in the studies or by imputing
possible values using the mean of values from compar-
able studies. The likelihood of publication bias will be
assessed through visual inspection of funnel plots and
with Egger’s regression test, provided there are at least
10 studies included in the meta-analysis.
Sub-group analyses
Whether the minimum change in BMI necessary to ef-
fect change in metabolic outcomes differs between the
following groups will be explored using sub-group ana-
lysis (provided there are sufficient studies in the sub-
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group) or meta-regression as appropriate: pubertal sta-
tus, gender, RCTs vs observational studies.
Sensitivity analyses
To assess whether imputing missing data affects the
pooled estimates, the main analyses will be repeated
using a more conservative imputation method (i.e. using
the maximum rather than mean appropriate value re-
ported in other studies) and by excluding studies in
which missing data was imputed.
Discussion
This will be the first systematic review of lifestyle treat-
ment interventions for obese children and adolescents to
establish the minimum change in BMI required to im-
prove metabolic health status. Whilst there is consensus
that reducing adiposity in cases of obesity is beneficial,
understanding how much body mass must be reduced
by to positively affect metabolic health is important to
ensure that weight management treatment interventions
are appropriately designed and evaluated to achieve clin-
ical rather than just statistical significance.
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